-

ValGenesis to Showcase Process Lifecycle Suite at BioProcessing Summit Europe 2026

SANTA CLARA, Calif.--(BUSINESS WIRE)--ValGenesis Inc., the global leader in digital validation lifecycle management, will showcase its Process Lifecycle Suite, part of the ValGenesis Smart GxP™ platform, at BioProcessing Summit Europe 2026, taking place March 10-12 in Barcelona. The event brings together bioprocessing innovators, scientists, and decision-makers shaping the future of modern biomanufacturing.

Attendees are invited to stop by Booth No. 35 to connect with the ValGenesis team and learn more.

Share

Many pharmaceutical and biotechnology companies, including cell and gene therapy developers, continue to manage process lifecycle activities through siloed systems and manual workflows. At Booth No. 35, ValGenesis will demonstrate how Process Lifecycle Suite connects and standardizes lifecycle execution, building quality into every stage of drug development while improving traceability, ensuring proactive compliance, and maintaining a continued state of control.

“Process validation is not a one-time event—it is an ongoing lifecycle that must remain connected and inspection-ready,” said Steve Reynolds, chief revenue officer at ValGenesis. “We look forward to sharing how organizations can transform fragmented validation activities into a connected, end-to-end lifecycle strategy.”

Why visit Booth No. 35?

  • One-on-one consultations tailored to organizational maturity, compliance, and performance goals
  • Strategies for implementing a digital, end-to-end process lifecycle framework
  • Best practices for maintaining inspection readiness through continuous lifecycle management
  • Methods to scale process lifecycle execution across global manufacturing networks

Attendees are invited to stop by Booth No. 35 to connect with the ValGenesis team and learn more.

About ValGenesis Inc.

ValGenesis, Inc. is the global leader in enterprise digital validation. Serving the life sciences industry for nearly two decades, ValGenesis enables companies to digitize their commissioning, qualification, and validation processes through its AI-enabled ValGenesis Smart GxP™ platform, which includes solutions for risk management, cleaning validation, continued process verification, and CMC development. ValGenesis helps customers worldwide reduce costs, improve compliance, and accelerate innovation. For more information, visit www.valgenesis.com.

###

Contacts

Further information
Althea D'Sylva, ValGenesis Communications, +1 510-445-0505 Ex.1026 althea.dsylva@valgenesis.com

ValGenesis Inc.


Release Versions

Contacts

Further information
Althea D'Sylva, ValGenesis Communications, +1 510-445-0505 Ex.1026 althea.dsylva@valgenesis.com

Social Media Profiles
More News From ValGenesis Inc.

LOTTE Biologics Implements ValGenesis e-Logbook Solution to Modernize QC Operations

SANTA CLARA, Calif.--(BUSINESS WIRE)--ValGenesis, Inc., the global leader in enterprise digital validation and compliance solutions, today announced that LOTTE Biologics, a rapidly growing contract development and manufacturing organization (CDMO) headquartered in Seoul, South Korea, has successfully gone live with the ValGenesis e-Logbook solution. The digital logbook management tool transforms operational execution in regulated environments with complete traceability and control. Founded in 2...

ValGenesis to Exhibit Smart GxP™ at 2026 ISPE Europe Annual Conference

SANTA CLARA, Calif.--(BUSINESS WIRE)--ValGenesis Inc., the global leader in digital validation lifecycle management, will exhibit its Smart GxP™ platform at the ISPE Europe Annual Conference, April 20-22, in Copenhagen, Denmark. As pharmaceutical and biotechnology manufacturers navigate increasing regulatory expectations, operational complexity, and the integration of artificial intelligence into GxP environments, ValGenesis product specialists will be on-site to connect with pharmaceutical eng...

ValGenesis to Join Industry Peers at 2026 ISPE San Francisco Vendor Night

SANTA CLARA, Calif.--(BUSINESS WIRE)--ValGenesis Inc., the global leader in enterprise digital validation lifecycle management, will attend the 33rd Annual ISPE San Francisco Vendor Night on March 19, 2026, at Oracle Park in San Francisco. Vendor Night is one of the Bay Area’s largest gatherings for professionals across the biotechnology, pharmaceutical, and medical device manufacturing sectors, drawing nearly 2,000 attendees, including engineers, consultants, government agencies, and academic...
Back to Newsroom